INVO Bioscience Inc (INVO)
0.89
+0.02
(+2.29%)
USD |
NASDAQ |
May 24, 16:00
0.88
-0.01
(-1.12%)
After-Hours: 20:00
INVO Bioscience Enterprise Value: 12.30M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 24, 2024 | 12.30M |
May 23, 2024 | 12.23M |
May 22, 2024 | 12.40M |
May 21, 2024 | 12.40M |
May 20, 2024 | 12.45M |
May 17, 2024 | 12.67M |
May 16, 2024 | 12.72M |
May 15, 2024 | 12.99M |
May 14, 2024 | 13.17M |
May 13, 2024 | 13.55M |
May 10, 2024 | 12.75M |
May 09, 2024 | 12.38M |
May 08, 2024 | 12.45M |
May 07, 2024 | 12.45M |
May 06, 2024 | 12.18M |
May 03, 2024 | 12.43M |
May 02, 2024 | 12.45M |
May 01, 2024 | 12.71M |
April 30, 2024 | 12.71M |
April 29, 2024 | 12.94M |
April 26, 2024 | 11.60M |
April 25, 2024 | 11.60M |
April 24, 2024 | 12.12M |
April 23, 2024 | 12.48M |
April 22, 2024 | 12.32M |
Date | Value |
---|---|
April 19, 2024 | 12.67M |
April 18, 2024 | 13.08M |
April 17, 2024 | 13.91M |
April 16, 2024 | 11.00M |
April 15, 2024 | 10.92M |
April 12, 2024 | 11.05M |
April 11, 2024 | 11.38M |
April 10, 2024 | 10.99M |
April 09, 2024 | 11.08M |
April 08, 2024 | 11.16M |
April 05, 2024 | 11.15M |
April 04, 2024 | 11.19M |
April 03, 2024 | 11.32M |
April 02, 2024 | 11.32M |
April 01, 2024 | 11.56M |
March 31, 2024 | 11.87M |
March 28, 2024 | 11.49M |
March 27, 2024 | 11.41M |
March 26, 2024 | 11.05M |
March 25, 2024 | 11.37M |
March 22, 2024 | 11.35M |
March 21, 2024 | 11.27M |
March 20, 2024 | 11.17M |
March 19, 2024 | 11.07M |
March 18, 2024 | 11.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.149M
Minimum
Jun 21 2023
81.21M
Maximum
Mar 09 2021
23.57M
Average
26.87M
Median
Apr 08 2020
Enterprise Value Benchmarks
Abbott Laboratories | 189.00B |
Perspective Therapeutics Inc | 755.01M |
Xtant Medical Holdings Inc | 120.35M |
Asensus Surgical Inc | 57.64M |
Catheter Precision Inc | 2.564M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.596M |
Revenue (Quarterly) | 1.576M |
Total Expenses (Quarterly) | 2.523M |
EPS Diluted (Quarterly) | -0.42 |
Gross Profit Margin (Quarterly) | 46.06% |
Profit Margin (Quarterly) | -101.3% |
Earnings Yield | -559.6% |
Normalized Earnings Yield | -542.26 |